Collaboration is at the heart of what we do. We are a unique partnership tackling major scientific problems and generating solutions to the emerging health challenges of the 21st century.
Our founders are the UK's three largest funders of biomedical research: the MRC, Cancer Research UK and Wellcome, and three of its leading universities: UCL, Imperial College London and King's College London.
The partnership occurs in the context of a strong national commitment to life sciences research and innovation, reflected in the government's Strategy for UK Life Sciences and associated plans to boost innovation uptake within the NHS.
We bring together the significant biomedical and physical science strengths that exist within London, while fostering interaction with other centres of excellence across the UK.
We actively develop and promote new forms of partnership, both with our founders and the broader UK scientific community. By creating an integrated biomedical research effort that brings together the best minds from research, academia and industry, we are maximising opportunities for scientific discovery, for world-class training, for translation to transform health and the economy, and for engagement with audiences outside science.
A multi and interdisciplinary approach
Biomedicine is becoming more and more dependent on other scientific disciplines, including physics, chemistry, engineering and computational sciences. To succeed in this changing environment, we must be receptive to new techniques and approaches and avoid being constrained by traditional disciplinary boundaries.
That is why our internal structure is not arranged along disciplinary lines. Instead, we encourage the development of 'interest groups' that bring together researchers to share insights and plan activities in areas of common scientific interest.
Our 1250 scientists work in a building designed to encourage joint working. Scientists are drawn together in collaboration spaces at the centre of each floor.
Our work with our university founders gives us access to a wide range of expertise and facilities. The collaboration we’re supporting will pay dividends to everyone involved, for example by introducing new data, new methodologies, concepts and perspectives and by stimulating novel approaches to problems.